Article
p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma
20 Apr 2016
Abstract excerpt
Metastatic progression is the major cause of death in osteosarcoma, the most common bone malignancy in children and young adults. However, prognostic biomarkers and efficacious targeted treatments for metastatic disease remain lacking. Using an immunoproteomic approach, we discovered that autoantibodies against the cell-cycle kinase inhibitor p27 (KIP1, CDKN1B) were elevated in plasma of high-risk osteosarcoma...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
